A Gram-positive obligate anaerobe and key estrobolome member that links metabolic dysbiosis to hormone-driven diseases, particularly endometriosis. E. lenta is remarkable for its ability to inactivate cardiac glycosides (like digoxin) and to produce beta-glucuronidase, the enzyme responsible for deconjugating and reactivating estrogen in the gut. Its abundance modulates systemic estrogen exposure through the enterohepatic circulation -- making E. lenta a central node in the estrogen recirculation axis. Critical cofactors are iron and molybdenum, both of which are elevated in endometriosis.
The Estrobolome and Beta-Glucuronidase
The Enterohepatic Estrogen Circulation
The human estrogen recirculation system:
1. Hepatic conjugation: The liver conjugates estrogen (E2) to estrogen glucuronide (E2G) via UDP-glucuronosyltransferase (UGT).
2. Biliary excretion: E2G is excreted into the bile and reaches the intestinal lumen.
3. Bacterial deconjugation: Intestinal bacteria expressing beta-glucuronidase cleave E2G back to free E2.
4. Reabsorption: Free E2 is reabsorbed across the intestinal epithelium and returns to systemic circulation.
5. Cycle: Free E2 re-enters the liver for re-conjugation, extending the half-life and increasing cumulative estrogen exposure.
Eggerthella lenta as Estrobolome Node
- E. lenta is a prolific beta-glucuronidase producer and a core estrobolome member alongside bacteroides fragilis, clostridium, and other anaerobes.
- Higher E. lenta abundance correlates with:
- Elevated urinary estrogen metabolites (indicating increased reabsorption and systemic circulation).
- Higher serum estradiol in women, even when controlling for ovarian production.
- Enrichment in estrogen-dependent diseases: endometriosis, PCOS, breast cancer.
Iron and Molybdenum for Beta-Glucuronidase
- Beta-glucuronidase (EC 3.2.1.31) is an iron-containing metalloenzyme; some isoforms also contain molybdenum cofactors in regulatory or catalytic domains.
- Iron availability directly modulates E. lenta growth and beta-glucuronidase expression.
- Molybdenum is a cofactor for multiple oxidoreductases and may be rate-limiting for E. lenta beta-glucuronidase activity.
- In endometriosis, both iron and molybdenum are often elevated (from bleeding and tissue inflammation), creating conditions favoring E. lenta expansion and maximal estrogen deconjugation.
The Endometriosis Connection
The Endometriosis Microbiome Signature
Endometriosis is characterized by:
- Elevated estrogen (both systemic and intra-lesional, partly driven by β-glucuronidase activity).
- Enriched estrobolome members including eggerthella lenta, bacteroides fragilis, and other β-glucuronidase producers.
- Elevated iron and hemoglobin degradation products from ectopic endometrial bleeding.
- Elevated molybdenum (elevated alongside iron in inflammatory lesions).
- Reduced gut barrier function (elevated zonula occludens-1 permeability; altered tight junction protein expression).
Estrogen Feedback on Dysbiosis
- Elevated systemic estrogen (driven by E. lenta-mediated estrogen reabsorption) perpetuates dysbiosis:
- Estrogen is bacteriostatic to many commensals (faecalibacterium prausnitzii, bifidobacterium).
- Estrogen favors estrobolome members like E. lenta.
- This creates a vicious cycle: E. lenta enrichment → increased estrogen reabsorption → higher systemic estrogen → further suppression of non-estrobolome commensals → E. lenta dominance solidifies.
Dysbiosis and Intestinal Permeability in Endometriosis
- Loss of faecalibacterium prausnitzii and akkermansia muciniphila (suppressed by elevated estrogen) → reduced butyrate production → loss of HDAC inhibition → downregulation of tight junction genes (claudins, ZO-1, occludin).
- Increased intestinal permeability allows elevated LPS translocation.
- Systemic LPS activates TLR4 on macrophages and dendritic cells → IL-6, IL-8, IL-17 production → perpetuates both endometriosis lesion inflammation and gut dysbiosis.
Cardiac Glycoside Inactivation
Digoxin Metabolism
- E. lenta (and some other Gram-positive anaerobes) encodes cardiac glycoside-inactivating enzymes that metabolize digoxin and other cardiac glycosides to inactive metabolites.
- This has important clinical pharmacokinetics implications: patients with high E. lenta abundance have reduced digoxin bioavailability and may require higher doses to achieve therapeutic levels.
- Conversely, antibiotic treatment that reduces E. lenta can precipitate digoxin toxicity if the dose is not adjusted.
Enzyme Substrate and Metal Cofactors
- The mechanism of digoxin inactivation likely involves hydroxylation or other redox modifications.
- These reactions typically require metal cofactors (iron, molybdenum) and electron donors.
- This activity is another example of how E. lenta metabolism is sensitive to metal availability.
Iron Biology and Pathogenic Context
Iron Acquisition
- E. lenta possesses iron uptake systems and requires iron for:
- Beta-glucuronidase and other redox enzymes.
- Cytochrome c oxidases for anaerobic respiration.
- Ribonucleotide reductase for nucleotide synthesis.
- In endometriosis, where hemoglobin from bleeding ectopic lesions provides abundant iron/heme, E. lenta proliferates.
Iron as a Selective Pressure
- High-iron conditions in endometriosis lesions select for iron-dependent pathobionts like E. lenta over commensals with lower iron demand.
- This again exemplifies the metals as selective pressures principle: elevated iron in endometriosis tissue selects for dysbiotic estrobolome members.
Ecological Interactions
Estrobolome Community
E. lenta operates within a broader estrobolome consortium including:
- bacteroides fragilis -- also produces beta-glucuronidase; can be commensal or pathobiont depending on toxigenic strain.
- clostridium species (e.g., C. scindens) -- deconjugate estrogen via different mechanisms; produce estrobolome-specific metabolites.
- blautia and other Firmicutes -- some strains produce beta-glucuronidase; context-dependent roles.
Dysbiotic Enrichment Context
- E. lenta enrichment is observed alongside prevotella copri, ruminococcus gnavus, and bacteroides vulgatus in endometriosis microbiome profiles.
- Depleted commensals (faecalibacterium prausnitzii, akkermansia muciniphila, bifidobacterium) that would normally compete for ecological niches or produce anti-inflammatory metabolites are reduced.
Molybdenum Metabolism
Molybdenum Cofactor (Moco)
- E. lenta, like all anaerobes with oxidoreductases, requires molybdenum cofactor (Moco) for multiple enzymes.
- Moco is synthesized de novo by bacteria from molybdenum (Mo) and organic precursors.
- Molybdenum availability may be rate-limiting for E. lenta beta-glucuronidase expression, particularly in endometriosis where molybdenum elevation is part of the metallomic signature.
Therapeutic Implications
Estrogen Modulation via Dysbiosis
- Prebiotic therapy promoting faecalibacterium prausnitzii, akkermansia muciniphila, and bifidobacterium can reduce E. lenta dominance and lower circulating estrogen.
- Restoring SCFA diversity (especially butyrate) restores tight junction function and reduces LPS-driven inflammation.
Estrogen-Suppressing Interventions
- Dietary interventions that reduce estrogen reabsorption (high-insoluble-fiber diets that reduce beta-glucuronidase activity) may lower E. lenta growth and estrogen circulation simultaneously.
Metal Modulation
- Iron restriction (avoiding excess red meat, iron supplements) may disfavor E. lenta and other iron-dependent dysbiotic pathobionts.
- Molybdenum status in endometriosis is understudied; if molybdenum is indeed rate-limiting for E. lenta beta-glucuronidase, molybdenum restriction might offer a novel approach.
Connections
- iron -- iron-dependent for beta-glucuronidase and core metabolism; elevated iron in endometriosis selects for E. lenta
- molybdenum -- cofactor for redox enzymes and beta-glucuronidase regulation; elevated in endometriosis
- endometriosis -- enriched in endo microbiome; beta-glucuronidase drives estrogen recirculation and lesion inflammation
- estrogen -- E. lenta beta-glucuronidase extends estrogen half-life; elevated estrogen selectively favors E. lenta over competitors
- estrobolome -- core estrobolome member alongside bacteroides fragilis and clostridium
- beta glucuronidase -- key virulence enzyme; iron and molybdenum cofactors modulate activity
- enterohepatic circulation -- E. lenta extends estrogen recirculation via deconjugation
- dysbiosis -- enriched in endometriosis; depletes commensal barrier-protective taxa
- faecalibacterium prausnitzii -- co-depleted with E. lenta enrichment; loss of butyrate-mediated tight junction support
- cardiac glycoside metabolism -- E. lenta inactivates digoxin; clinical pharmacokinetic implications
- barrier function -- dysbiosis with E. lenta enrichment compromises tight junctions via loss of SCFA